T-Mobile, Toyota Motor, Vertex Pharmaceuticals, BK Technologies and Servotronics are part of the Zacks top Analyst Blog.

Satralizumab is under clinical development by F. Hoffmann-La Roche and currently in Phase III for Demyelinating Diseases.

NanoViricides, Inc. (NYSE American:NNVC) (the 'Company'), says that its broad-spectrum antiviral drug candidate NV-387 is the best weapon to ...

FREDERICK, Md., Dec. 26, 2024 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc.® ("TOMI”) (NASDAQ: TOMZ), a global ...

It manufactures a very wide spectrum of ethical pharmaceutical products OTC products and nutraceuticals. Their dosage forms range includes tablets capsules soft gelatin capsules... Apportionment of ...

The company manufactures and markets a large basket of pharmaceutical formulations covering a broad spectrum of chronic and acute therapies. It includes generics branded generics complex or difficult ...

Abbott has announced it has reached an agreement with DexCom, Inc. to settle all outstanding patent disputes between the ...

New York, United States - November 8, 2023 (Newsfile Corp.) (Investorideas Newswire) Ultra-pure water is water that meets stringent limits or specifications for biological organisms (including ...

The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including ServiceNow, Inc. (NOW), Advanced ...

It further advances the UAE's drug distribution infrastructure and bolsters drug security ...

MyGender Dolls’ aims to foster children’s gender exploration through ‘interactive’ paper dolls with interchangeable ‘internal ...